COVID-19 Research

Title :

Design, validation, and development of novel peptidomimetic therapeutics targeting SARS-CoV-2 replication

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

COVID-19 Diagnostics

Principal Investigator :

Dr Arockiasamy Arulandu, Group Leader, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi

Timeline Start Year :


Contact info :


Executive Summary :

The aim of this study is to deliver novel peptidomimetic inhibitors targeting Mpro and PLpro with therapeutic potential, validated in vitro and in vivo using recent animal models for SARS-CoV-2.

Organizations involved